Morpho, Inc. (TYO:3653)
Japan · Delayed Price · Currency is JPY 1,097.00
-15.00 (-1.35%)
Sep 28, 2026, 3:30 PM JST
Morpho Balance Sheet
Financials in millions JPY. Fiscal year is November - October.
Millions JPY. Fiscal year is Nov - Oct.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Cash & Equivalents | 1,753 | 2,525 | 2,935 | 2,712 | 3,059 | 3,391 |
Cash & Short-Term Investments | 1,753 | 2,525 | 2,935 | 2,712 | 3,059 | 3,391 |
Cash Growth | -26.13% | -13.97% | 8.22% | -11.34% | -9.79% | -23.57% |
Accounts Receivable | 519 | 590 | 655 | 517 | 421 | 419 |
Other Receivables | - | 1 | 3 | - | - | - |
Receivables | 519 | 591 | 658 | 517 | 421 | 419 |
Inventory | 51 | 18 | 1 | 33 | 10 | 12 |
Prepaid Expenses | 80 | 96 | 74 | 61 | 17 | 39 |
Other Current Assets | 44 | 19 | 21 | 7 | 85 | 216 |
Total Current Assets | 2,447 | 3,249 | 3,689 | 3,330 | 3,592 | 4,077 |
Property, Plant & Equipment | 46 | 66 | 49 | 52 | 25 | 125 |
Long-Term Investments | 513 | 533 | 342 | 307 | 237 | 301 |
Other Intangible Assets | 211 | 296 | 154 | 12 | - | 44 |
Long-Term Deferred Tax Assets | - | - | 26 | 5 | 4 | - |
Other Long-Term Assets | 2 | 2 | 2 | 1 | 2 | 3 |
Total Assets | 3,219 | 4,146 | 4,262 | 3,707 | 3,860 | 4,550 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Accounts Payable | 172 | 212 | 180 | 96 | 126 | 110 |
Accrued Expenses | 23 | 7 | 47 | 56 | 24 | 17 |
Current Income Taxes Payable | 111 | 94 | 169 | 152 | 102 | 89 |
Other Current Liabilities | 121 | 154 | 212 | 204 | 200 | 146 |
Total Current Liabilities | 427 | 467 | 608 | 508 | 452 | 362 |
Long-Term Deferred Tax Liabilities | 46 | 52 | - | 24 | 5 | - |
Other Long-Term Liabilities | 17 | 8 | 15 | 27 | 5 | 38 |
Total Liabilities | 490 | 527 | 623 | 559 | 462 | 400 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Common Stock | 100 | 1,858 | 1,858 | 1,783 | 1,783 | 1,783 |
Additional Paid-In Capital | 3,199 | 1,818 | 1,808 | 1,732 | 1,732 | 1,732 |
Retained Earnings | -427 | 113 | 190 | -110 | 189 | 847 |
Treasury Stock | -368 | -332 | -367 | -370 | -370 | -210 |
Comprehensive Income & Other | 225 | 162 | 150 | 113 | 64 | -2 |
Total Common Equity | 2,729 | 3,619 | 3,639 | 3,148 | 3,398 | 4,150 |
Shareholders' Equity | 2,729 | 3,619 | 3,639 | 3,148 | 3,398 | 4,150 |
Total Liabilities & Equity | 3,219 | 4,146 | 4,262 | 3,707 | 3,860 | 4,550 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Net Cash (Debt) | 1,753 | 2,525 | 2,935 | 2,712 | 3,059 | 3,391 |
Net Cash Growth | -26.13% | -13.97% | 8.22% | -11.34% | -9.79% | -23.57% |
Net Cash Per Share | 335.35 | 481.66 | 570.46 | 528.75 | 595.16 | 628.11 |
Filing Date Shares Outstanding | 5.16 | 5.25 | 5.23 | 5.13 | 5.13 | 5.26 |
Total Common Shares Outstanding | 5.16 | 5.25 | 5.23 | 5.13 | 5.13 | 5.26 |
Working Capital | 2,020 | 2,782 | 3,081 | 2,822 | 3,140 | 3,715 |
Book Value Per Share | 528.64 | 689.02 | 696.34 | 613.76 | 662.50 | 789.14 |
Tangible Book Value | 2,518 | 3,323 | 3,485 | 3,136 | 3,398 | 4,106 |
Tangible Book Value Per Share | 487.76 | 632.66 | 666.88 | 611.42 | 662.50 | 780.77 |
Order Backlog | - | 62.31 | 114.44 | 69.83 | 270.82 | 223.97 |